Novel Aza-Podophyllotoxin Derivative in Triple Negative Breast Cancer

ABSTRACT: Four cell lines (MCF10A, MCF12A, MDA-MB-231, and MDA-MB-468) were treated with a novel drug candidate.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Sharon Pitteri  

LAB HEAD: Sharon Pitteri

PROVIDER: PXD018929 | Pride | 2020-11-09

REPOSITORIES: Pride